TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - SANZ GROUPAR Stock

Certificat

DE000SU5RSQ4

Market Closed - Boerse Frankfurt Warrants 15:48:45 2024-05-31 EDT
0.29 EUR -17.14% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - SANZ GROUPAR
3 months-66.67%
Current year-70.10%
Date Price Change
24-05-31 0.29 -17.14%
24-05-30 0.35 +2.94%
24-05-29 0.34 +25.93%
24-05-28 0.27 -.--%
24-05-27 0.27 -6.90%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 03:48 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying SANDOZ GROUP AG
IssuerLogo Issuer Société Générale Société Générale
WKN SU5RSQ
ISINDE000SU5RSQ4
Date issued 2023-12-13
Strike 34.97 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 0.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.04
Lowest since issue 0.24

Company Profile

Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Sector
-
More about the company

Ratings for Sandoz Group AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Sandoz Group AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
35.48 USD
Average target price
39.82 USD
Spread / Average Target
+12.23%
Consensus